WSE:RVU

Ryvu Therapeutics S.a Stock Forecast

etoro logo Buy RVU
*Your capital is at risk
23.60zł
-0.550 (-2.28%)
At Close: Nov 18, 2025
AI Analysis AI Analysis of RVU.WA
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Ryvu Therapeutics S.A. stock upgraded from Sell Candidate to Hold/Accumulate after Tuesday trading session
(Updated on Nov 18, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Nov 18, 2025

The Ryvu Therapeutics S.A. stock price fell by -2.28% on the last day (Tuesday, 18th Nov 2025) from 24.15zł to 23.60zł. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.00% from a day low at 23.30zł to a day high of 24.00zł. The price has fallen in 7 of the last 10 days and is down by -5.22% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 thousand shares and in total, 14 thousand shares were bought and sold for approximately 338.73zł thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -18.57% during the next 3 months and, with a 90% probability hold a price between 18.24zł and 20.89zł at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

RVU.WA Signals & Forecast

There are mixed signals in the stock today. The Ryvu Therapeutics S.A. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at 23.94zł and 25.65zł. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. A buy signal was issued from a pivot bottom point on Friday, November 07, 2025, and so far it has risen 2.83%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Ryvu Therapeutics S.A. stock

Ryvu Therapeutics S.A. finds support from accumulated volume at 23.10zł and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved 0.700zł between high and low, or 3.00%. For the last week the stock has had daily average volatility of 4.78%.

Our recommended stop-loss: 22.34zł (-5.35%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (RVU.WA) For The Upcoming Trading Day Of Wednesday 19th

For the upcoming trading day on Wednesday, 19th we expect Ryvu Therapeutics S.A. to open at 23.63zł, and during the day (based on 14 day Average True Range), to move between 23.06zł and 24.14zł, which gives a possible trading interval of +/-1.07zł (+/-4.65%) up or down from last closing price. If Ryvu Therapeutics S.A. takes out the full calculated possible swing range there will be an estimated 4.65% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at 23.10zł (2.12%) than the resistance at 24.15zł (2.33%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Ryvu Therapeutics S.A. stock A Buy?

Ryvu Therapeutics S.A. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.952 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 19, 2025 - 23.63zł ( 0.141%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

RVU.WA Performance

Trading levels for RVU.WA

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 24.33 3.11%
R2 24.07 1.97%
R1 23.90 1.27%
Price 23.60
S1 23.37 -0.99%
S2 23.20 -1.69%
S3 22.93 -2.82%

Accumulated Volume Support & Resistance Levels

Level Price
R3 25.00 5.93%
R2 24.80 5.08%
R1 24.15 2.33%
Price 23.60
S1 23.10 -2.12%
S2 22.95 -2.75%
S3 0 -

FAQ

What is the symbol for Ryvu Therapeutics S.A. Stock and on which exchange is it traded?
The symbol for Ryvu Therapeutics S.A. is RVU.WA and it is traded on the WSE (Warsaw Stock Exchange).

Should I buy or sell Ryvu Therapeutics S.A. Stock?
Ryvu Therapeutics S.A. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Ryvu Therapeutics S.A. Stock?
Ryvu Therapeutics S.A. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ryvu Therapeutics S.A. Stock.

What's the current price of Ryvu Therapeutics S.A. Stock?
As of the end of day on the Nov 18, 2025, the price of an Ryvu Therapeutics S.A. (RVU.WA) share was 23.60zł.

What is the 52-week high and low for Ryvu Therapeutics S.A. Stock?
The 52-week high for Ryvu Therapeutics S.A. Stock is 52.80zł and the 52-week low is 17.62zł.

What is the market capitalization of Ryvu Therapeutics S.A. Stock?
As of the Nov 18, 2025, the market capitalization of Ryvu Therapeutics S.A. is 545.63M.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE